These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25459934)

  • 1. Development of a method to quantify clindamycin in vitreous humor of rabbits' eyes by UPLC-MS/MS: application to a comparative pharmacokinetic study and in vivo ocular biocompatibility evaluation.
    Fernandes-Cunha GM; Gouvea DR; Fulgêncio Gde O; Rezende CM; da Silva GR; Bretas JM; Fialho SL; Lopes NP; Silva-Cunha A
    J Pharm Biomed Anal; 2015 Jan; 102():346-52. PubMed ID: 25459934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
    Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
    Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus-loaded PLGA implants: in vivo release and ocular toxicity.
    Souza MC; Fialho SL; Souza PA; Fulgêncio GO; Da Silva GR; Silva-Cunha A
    Curr Eye Res; 2014 Jan; 39(1):99-102. PubMed ID: 24325382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
    De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
    Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Mycophenolic acid in the vitreous humor using the HPLC-ESI-MS/MS method: application of intraocular pharmacokinetics study in rabbit eyes with ophthalmic implantable device.
    Martins Duarte Byrro R; de Oliveira Fulgêncio G; Rocha Chellini P; da Silva Cunha A; Pianetti GA
    J Pharm Biomed Anal; 2013 Oct; 84():30-5. PubMed ID: 23797039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma.
    Kim J; Kudisch M; Mudumba S; Asada H; Aya-Shibuya E; Bhisitkul RB; Desai TA
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4341-6. PubMed ID: 27556217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
    Kane FE; Green KE
    J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide-Loaded Poly(Lactic-co-Glycolic Acid) Intravitreal Implants: In Vitro and In Vivo Evaluation.
    Solano AGR; de Fátima Pereira A; de Faria LGA; Fialho SL; de Oliveira Patricio PS; da Silva-Cunha A; Fulgêncio GO; da Silva GR; Pianetti GA
    AAPS PharmSciTech; 2018 May; 19(4):1652-1661. PubMed ID: 29516291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes.
    Bhagat R; Zhang J; Farooq S; Li XY
    J Ocul Pharmacol Ther; 2014 Dec; 30(10):854-8. PubMed ID: 25411827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.
    de Almeida FP; Saliba JB; Ribeiro JA; Siqueira RC; Fialho SL; Silva-Cunha A; Jorge R; Messias A
    Doc Ophthalmol; 2015 Dec; 131(3):207-14. PubMed ID: 26576763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-Loaded Intravitreal Implant for Effective Treatment of Experimental Uveitis.
    Paiva MRB; Vasconcelos-Santos DV; Vieira LC; Fialho SL; Silva-Cunha A
    AAPS PharmSciTech; 2021 Jan; 22(1):35. PubMed ID: 33404988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and sensitive LC/MS/MS assay for the quantitation of brimonidine in ocular fluids and tissues.
    Jiang S; Chappa AK; Proksch JW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):107-14. PubMed ID: 19109079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel.
    Zhang L; Shen W; Luan J; Yang D; Wei G; Yu L; Lu W; Ding J
    Acta Biomater; 2015 Sep; 23():271-281. PubMed ID: 26004219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive evaluation of toxicity in vitreoretinal domain following insertion of sustained release methotrexate micro-implant.
    Manna S; Caixeta Faraj RQ; Riemann B; Rao MB; Nair V; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK
    Exp Eye Res; 2021 Apr; 205():108505. PubMed ID: 33617850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
    Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
    Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of triamcinolone acetonide in ocular tissues after intravitreal injection to rabbit using liquid chromatography-tandem mass spectrometry.
    Zhang SQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):548-52. PubMed ID: 21296037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.